The growth track for AMN Healthcare Services Inc. (AMN) has changed recently

AMN Healthcare Services Inc. (NYSE: AMN) stock fell -4.84% on Tuesday to $96.75 against a previous-day closing price of $101.67. With 1.13 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.68 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $102.50 whereas the lowest price it dropped to was $94.95. The 52-week range on AMN shows that it touched its highest point at $129.04 and its lowest point at $82.75 during that stretch. It currently has a 1-year price target of $148.00. Beta for the stock currently stands at 0.34.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AMN was down-trending over the past week, with a drop of -7.88%, but this was down by -7.01% over a month. Three-month performance dropped to -15.79% while six-month performance fell -14.41%. The stock gained 3.56% in the past year, while it has lost -5.90% so far this year. A look at the trailing 12-month EPS for AMN yields 10.38 with Next year EPS estimates of 8.47. For the next quarter, that number is 2.14. This implies an EPS growth rate of 359.90% for this year and -26.97% for next year. EPS is expected to grow by 19.35% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 26.00%.

Float and Shares Shorts:

At present, 43.78 million AMN shares are outstanding with a float of 42.99 million shares on hand for trading. On Oct 13, 2022, short shares totaled 4.66 million, which was 10.77% higher than short shares on Sep 14, 2022. In addition to Ms. Susan R. Salka as the firm’s Pres, CEO & Director, Mr. Jeffrey R. Knudson serves as its CFO, Chief Accounting Officer & Treasurer.

Institutional Ownership:

Through their ownership of 102.63% of AMN’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 9.34% of AMN, in contrast to 58.91% held by mutual funds. Shares owned by individuals account for 44.98%. As the largest shareholder in AMN with 14.60% of the stake, BlackRock Fund Advisors holds 6,328,645 shares worth 6,328,645. A second-largest stockholder of AMN, The Vanguard Group, Inc., holds 5,285,996 shares, controlling over 12.20% of the firm’s shares. SSgA Funds Management, Inc. is the third largest shareholder in AMN, holding 1,498,150 shares or 3.46% stake. With a 7.39% stake in AMN, the iShares Core S&P Small Cap ETF is the largest stakeholder. A total of 3,200,661 shares are owned by the mutual fund manager. The Vanguard Total Stock Market Index, which owns about 3.05% of AMN stock, is the second-largest Mutual Fund holder. It holds 1,319,713 shares valued at 135.69 million. Vanguard Small Cap Index Fund holds 2.58% of the stake in AMN, owning 1,116,556 shares worth 114.8 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AMN since 9 analysts follow the stock currently. There are 8 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With AMN analysts setting a high price target of $185.00 and a low target of $130.00, the average target price over the next 12 months is $148.00. Based on these targets, AMN could surge 91.21% to reach the target high and rise by 34.37% to reach the target low. Reaching the average price target will result in a growth of 52.97% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. AMN will report FY 2022 earnings on 02/15/2024. Analysts have provided yearly estimates in a range of $11.69 being high and $10.10 being low. For AMN, this leads to a yearly average estimate of $11.43. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. AMN Healthcare Services Inc. surprised analysts by $0.20 when it reported $2.57 EPS against a consensus estimate of $2.37. The surprise factor in the prior quarter was $0.34. Based on analyst estimates, the high estimate for the next quarter is $2.26 and the low estimate is $1.76. The average estimate for the next quarter is thus $2.14.

Summary of Insider Activity:

Insiders traded AMN stock several times over the past three months with 7 Buys and 14 Sells. In these transactions, 19,601 shares were bought while 21,897 shares were sold. The number of buy transactions has increased to 19 while that of sell transactions has risen to 25 over the past year. The total number of shares bought during that period was 76,777 while 50,868 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *